Brind.

Deutsche Bank analysts questioned Select Medical regarding the company's performance due to regulatory changes and Medicare reimbursements.

1 report, 0 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Select Medical Deutsche Bank CMS

Keep exploring

The entities involved

Select Medical
American healthcare company
- Trump pledged to unleash American oil and gas production, involving Elevance Health.Sun 05:25
Deutsche Bank
German global banking and financial services company
- Geopolitical risk adds to UK fiscal pressures as renewed fighting drives up oil prices, prompting economists to analyze market impacts.Mon 15:09
- Bank of America upgraded a rating to buy and suggested a potential equity stake in a Caribbean resort chain, supported by Deutsche Bank.Mon 13:32
CMS
International law firm
- The Trump administration has issued mandates through CMS that specifically apply to Medicaid enrollees in the District of Columbia.Sun 20:19
- CMS, Jonathan Kellerman, and Mark Greaney are collaborating on educational technology and quantum computing in Cleveland.Sat 08:30

Related events

Medicare prescription changes affect Novo Nordisk's revenue outlook, coinciding with a Deutsche Bank stock downgrade.Aug 27
CMS provides alternative analysis of MA overpayments while MedPAC analyzes spending in the privatized Medicare program.Wed 21:08
CMS rules are impacting American healthcare costs, and Congress is involved in building on these rules for transparency.Aug 5

Coverage

Newest first; wire copies grouped

Jun 27Unknown outlet